Biblio Discovery — Demo Discovery Service

7 results for "Benjamin Lockshin"

Showing 1–7 · 0.82 seconds · RSS

  1. Journal Article

    Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial

    Michael J. Cork; Benjamin Lockshin; Andreas Pinter et al.

    Acta Dermato-Venereologica, Vol. 104 · 2024 · English · DOAJ Scopus

    In young children, atopic dermatitis (AD) imposes a multidimensional burden on many aspects of their quality of life (QoL) and that of their families. LIBERTY AD PRESCHOOL part B was a randomized, double- blinded, placebo-controlled phase 3 trial in 162 children (aged 6 months to 5 years) with…

  2. Journal Article

    The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel

    Joshua Burshtein; Milaan Shah; Danny Zakria et al.

    Dermatology and Therapy, Vol. 14 No. 2 · 2024 · English · DOAJ Scopus

    Abstract Introduction Psoriasis is a chronic inflammatory condition affecting the skin, joints, and several other organ systems with significant disease burden. Bimekizumab is the first monoclonal antibody targeting both interleukin (IL)-17A and interleukin-17F and has demonstrated efficacy for…

  3. Journal Article

    A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

    Andrew F. Alexis; Melinda Gooderham; Shawn G. Kwatra et al.

    Dermatology and Therapy, Vol. 14 No. 10 · 2024 · English · DOAJ Scopus

    Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label…

  4. Journal Article

    Chronic inflammation in psoriasis promotes visceral adiposity associated with noncalcified coronary burden over time

    Aparna Sajja; Khaled M. Abdelrahman; Aarthi S. Reddy et al.

    JCI Insight, Vol. 5 No. 22 · 2020 · English · DOAJ Scopus

    BACKGROUND Psoriasis is a chronic inflammatory skin disease associated with increased obesity, noncalcified coronary artery burden (NCB), and incident myocardial infarction. Here, we sought to assess the relationship among inflammation, visceral adipose tissue (VAT), and NCB. Furthermore, we…